Episode 454: Pulmonary Hypertension

The Clinical Problem Solvers51mApril 16, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “Episode 454: Pulmonary Hypertension” inside PodZeus.

AI-Generated Summary

This episode of The Clinical Problem Solvers presents a complex case of a 79-year-old woman with progressive fatigue, shortness of breath, and syncope who was referred to a pulmonary hypertension clinic. She had chronic hypoxemic respiratory failure on 5 liters of oxygen, a history of right heart failure, and was found to have severe pulmonary hypertension with elevated pulmonary artery pressures and normal pulmonary capillary wedge pressure—indicating pre-capillary disease. Despite aggressive management with diuresis and inotropes, her condition deteriorated rapidly. The key diagnostic dilemma arose when she worsened after starting epoprostenol, a pulmonary vasodilator, which is typically used in pulmonary arterial hypertension (PAH). This paradoxical deterioration raised suspicion for pulmonary veno-occlusive disease (PVOD), a rare and often fatal form of pulmonary hypertension that mimics PAH but is contraindicated for vasodilator therapy. The team ultimately concluded that PVOD was the likely diagnosis, supported by her isolated low DLCO, lack of alternative etiology, and clinical trajectory. The episode underscores the critical importance of recognizing PVOD, which can be easily missed due to its similarity to PAH and the risk of life-threatening pulmonary edema from inappropriate vasodilator use.

Key Takeaways
1

PVOD is a rare but deadly form of pulmonary hypertension that mimics PAH clinically and hemodynamically but worsens with pulmonary vasodilators.

2

A normal pulmonary capillary wedge pressure with elevated pulmonary artery pressure suggests pre-capillary pulmonary hypertension, but does not rule out PVOD.

3

The presence of isolated low DLCO, especially in a patient with chronic hypoxemia, should raise suspicion for underlying vascular or parenchymal lung disease.

4

Never assume a diagnosis of PAH without ruling out PVOD, especially when vasodilator therapy leads to clinical deterioration.

5

High-resolution CT chest is essential in evaluating chronic hypoxemia and pulmonary hypertension to detect subtle findings like interlobular septal thickening and central nodules characteristic of PVOD.

…and 2 more takeaways available in PodZeus

Chapters
0:00
10 min

Introduction and Case Presentation

The episode opens with a warm welcome from Maddy and Yusuf, setting the stage for a live virtual morning report. The case is introduced by Mark, a hospitalist at Stanford, who presents a 79-year-old woman with progressive fatigue, syncope, and a recent transfer from a pulmonary hypertension clinic. The patient’s history includes chronic hypoxemia, AFib, and prior hospitalization for right heart failure. The team begins to explore the differential diagnosis, focusing on the significance of syncope in a patient with pulmonary hypertension.

10:00
10 min

Diagnostic Framework and Initial Workup

The one thing that stuck out to me is I'm like... whoa, why is this patient on five liters at baseline? Like what is going on there, right?

Highlight
20:00
10 min

Right Heart Catheterization and Hemodynamic Patterns

This patient's RA pressure is 17 and his patient's wedge is five. So that reversal shows that the RV is doing really bad, right?

Highlight
30:00
10 min

Differential Diagnosis and the PVOD Hypothesis

In PVOD, these pulmonary vasodilators cause this life-threatening pulmonary edema. They are almost indistinguishable on echo findings... but the treatments are like, you know, in one, in PAH, the pulmonary vasodilators can be helpful. And in PVOD, they are really not.

Highlight
40:00
10 min

Clinical Deterioration and Final Diagnosis

The takeaway is it's a rare form of pulmonary hypertension, but it's very deadly and exactly based on the pathophysiology that Yusuf mentioned, pulmonary vasodilators cause this worsening because you get dilation of the pulmonary artery and then basically that enhances flow upstream to the site of obstruction and then get this life-starting pulmonary edema.

Highlight
High-Impact Quotes
In PVOD, these pulmonary vasodilators cause this life-threatening pulmonary edema. They are almost indistinguishable on echo findings... but the treatments are like, you know, in one, in PAH, the pulmonary vasodilators can be helpful. And in PVOD, they are really not.
Noah48:32
Viral: 90.0
The takeaway is it's a rare form of pulmonary hypertension, but it's very deadly and exactly based on the pathophysiology that Yusuf mentioned, pulmonary vasodilators cause this worsening because you get dilation of the pulmonary artery and then basically that enhances flow upstream to the site of obstruction and then get this life-starting pulmonary edema.
Maddy47:29
Viral: 85.0
This patient's RA pressure is 17 and his patient's wedge is five. So that reversal shows that the RV is doing really bad, right?
Mark35:49
Viral: 80.0
Speakers

Hosts

MaddyYusufMarkNoah

Guest

Maddy
Topics Discussed
pulmonary hypertension95%pulmonary veno-occlusive disease90%vasodilator therapy88%right heart catheterization85%diagnostic reasoning80%hypoxemia75%high-resolution ct chest72%cardiogenic shock70%
People & Brands

pulmonary hypertension

other

35xNeutral

Yusuf

person

22xPositive

Mark

person

20xPositive

Noah

person

18xPositive

Maddy

person

15xNeutral

pulmonary veno-occlusive disease

other

14xNegative

right heart catheterization

other

10xNeutral

WHO groups

other

8xNeutral

epoprostenol

product

6xNegative

pulmonary arterial hypertension

other

6xNeutral

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “Episode 454: Pulmonary Hypertension” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime